Science Talk

Advancing Efforts in Disease Interception

Ben Wiegand, Global Head of the World Without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent disease or identify it in its earliest stages for more effective treatments.